SCHEMBL87653

SCHEMBL87653

NN1CCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20609356 1.00 CA1 (0.37)
SCHEMBL7803625 1.00 CA1 (0.37)
SCHEMBL7004360 1.00
SCHEMBL18534322 1.00 CA1 (0.37)
SCHEMBL15899116 1.00 CA1 (0.37)
SCHEMBL23841220 1.00 CA1 (0.37)
SCHEMBL9824 1.00
SCHEMBL2253570 1.00
Hydrochloric Acid SCHEMBL475576 0.96
SCHEMBL31454129 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3051 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118755684-A Catalytic enzyme for producing chiral aromatic amine, N-heterocyclic amine and derivatives thereof with high optical purity, and preparation method and application thereof 杭州微远生物科技有限公司 2024-10-11 CN claimed
US-20240197711-A1 Combination Therapy for Cancer Treatment REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-06-20 US claimed
US-20240124419-A1 SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2024-04-18 US claimed
CN-117836290-A Synthesis method of bilirubin 株式会社毕丽斯 2024-04-05 CN claimed
CN-117813301-A Synthesis method of bilirubin 株式会社毕丽斯 2024-04-02 CN claimed
EP-4313029-A1 COMBINATION THERAPY FOR CANCER TREATMENT The Regents of The University of Michigan (US) 2024-02-07 EP claimed
CN-117337175-A Combination Therapy for Cancer Treatment 密歇根大学董事会 2024-01-02 CN claimed
EP-4288416-A2 SMALL MOLECULE INHIBITORS OF GRP78 AND USES THEREOF The Regents Of The University Of Michigan (US) 2023-12-13 EP claimed
CN-112654620-B Novel pyrazolopyridine compounds for the treatment of autoimmune diseases 豪夫迈·罗氏有限公司 2023-08-04 CN claimed
EP-3844159-B1 NOVEL PYRROLIDINYL AMIDE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE HOFFMANN LA ROCHE (CH) 2023-05-03 EP claimed
EP-0360261-B1 Substituted Imidazol[2,1-b] quinazolin-5(3H)-ones and related tricyclic compounds MERRELL DOW PHARMA (US) 1993-10-27 EP claimed
EP-0249452-B1 PROCESS FOR PRODUCING N-AMINOHEXAMETHYLENEIMINE UBE INDUSTRIES, LTD. (JP) 1990-11-07 EP claimed
EP-0360261-A1 Substituted Imidazol[2,1-b] quinazolin-5(3H)-ones and related tricyclic compounds MERRELL DOW PHARMACEUTICALS INC. (US) 1990-03-28 EP claimed
US-4877874-A Process for producing N-aminohexamethyleneimine UBE INDRUSTRIES, LTD. (JP) 1989-10-31 US claimed
EP-0249452-A1 Process for producing N-aminohexamethyleneimine UBE INDUSTRIES, LTD. (JP) 1987-12-16 EP claimed
EP-0092647-B1 NEW ACTIVE COMPOUNDS IN THE TREATMENT OF ULCERS AND SKIN ALLERGY SYMPTOMS MAGIS FARMACEUTICI S.p.A. (IT) 1987-01-14 EP claimed
EP-0155297-A4 THIOLCARBAMATE COMPOUNDS. UNITED STATES BORAX CHEM (US) 1986-07-23 EP claimed
EP-0155297-A1 THIOLCARBAMATE COMPOUNDS UNITED STATES BORAX & CHEMICAL CORPORATION (US) 1985-09-25 EP claimed
WO-1985001185-A1 THIOLCARBAMATE COMPOUNDS UNITED STATES BORAX & CHEMICAL CORPORATION (US) 1985-03-28 WO claimed
EP-0092647-A1 New active compounds in the treatment of ulcers and skin allergy symptoms MAGIS FARMACEUTICI S.p.A. (IT) 1983-11-02 EP claimed